Related Experiment Video
Updated: Mar 21, 2026
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.7K
Anxiety Sensitivity in Dermatological Patients.
Laura J Dixon1, Aaron A Lee2, Andres G Viana3
1Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS.
Psychosomatics
|May 4, 2016
Summary
Patients with psychodermatological conditions exhibit higher anxiety sensitivity (fear of anxiety symptoms) than those with non-psychodermatological disorders. Social concerns uniquely predict this difference, suggesting targeted treatments for anxiety sensitivity may benefit these patients.
Area of Science:
- Psychodermatology
- Anxiety Disorders
- Cognitive Vulnerability
Background:
- Anxiety symptoms are prevalent in dermatology patients, potentially worsening skin conditions.
- Anxiety sensitivity (AS), the fear of anxiety symptoms, is a key cognitive vulnerability factor relevant to dermatological patients.
Purpose of the Study:
- To compare anxiety sensitivity (AS) levels between patients with psychodermatological disorders (e.g., psoriasis) and non-psychodermatological disorders (e.g., skin cancer).
- To investigate if psychodermatological conditions are associated with higher AS compared to non-psychodermatological conditions.
Main Methods:
- Adult patients from outpatient dermatology clinics were recruited.
- Participants included individuals with psychodermatological (n=63) and non-psychodermatological (n=52) conditions.
- Self-report questionnaires assessed sociodemographics, general anxiety, and anxiety sensitivity (AS).
Main Results:
- Patients with psychodermatological conditions reported significantly higher AS than those with non-psychodermatological conditions (p < 0.05).
- Social concerns related to AS were the sole significant differentiator between the two groups (OR=1.13, 95% CI: 1.02-1.24) after controlling for general anxiety.
Conclusions:
- Findings support the link between AS and physical health, particularly in dermatology.
- Cognitive-behavioral interventions targeting AS reduction may be beneficial for managing psychodermatological conditions.
Related Concept Videos
01:18Anxiety: Overview
1.3K
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
1.3K
01:26Anxiolytic Drugs: Overview
1.4K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.4K
01:30Generalized Anxiety Disorder
1.0K
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
1.0K
01:29Asthma-I: Introduction
3.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
01:30Allergic Reactions: Anaphylaxis
142
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
142
01:28Social Anxiety Disorder
725
Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.
725